Incidence of metformin use in patients with age-related macular degeneration versus normal controls: A population-based study in Olmsted County, Minnesota.
Matthew R StarrLauren A DalvinJackson E AbouChehadeGena M DamentoMaria GarciaSaumya M ShahDavid O HodgeRaymond IezziSophie J BakriPublished in: Eye (London, England) (2022)
There appears to be an increased incidence of metformin use in patients without AMD compared to patients with dry AMD. Metformin's current role in the treatment of anti-aging diseases makes it a plausible target for use in the treatment of AMD, particularly dry AMD.